statistiche ricercatore

Continente	#
NA - Nord America	1.484
EU - Europa	592
AS - Asia	407
SA - Sud America	56
AF - Africa	10
Continente sconosciuto - Info sul continente non disponibili	1
Totale	2.550

Nazione	#
US - Stati Uniti d'America	1.470
IT - Italia	194
SG - Singapore	150
GB - Regno Unito	142
CN - Cina	97
SE - Svezia	67
HK - Hong Kong	59
DE - Germania	45
BR - Brasile	44
VN - Vietnam	37
RU - Federazione Russa	29
FR - Francia	25
TR - Turchia	22
FI - Finlandia	17
UA - Ucraina	17
ID - Indonesia	14
BG - Bulgaria	10
CZ - Repubblica Ceca	8
ES - Italia	8
AR - Argentina	6
BE - Belgio	6
JP - Giappone	6
NL - Olanda	6
CA - Canada	5
IN - India	5
KR - Corea	5
LT - Lituania	4
MA - Marocco	4
MX - Messico	4
PL - Polonia	4
ZA - Sudafrica	4
AT - Austria	3
IR - Iran	3
MY - Malesia	3
CO - Colombia	2
IE - Irlanda	2
KG - Kirghizistan	2
PE - Perù	2
SK - Slovacchia (Repubblica Slovacca)	2
AZ - Azerbaigian	1
BZ - Belize	1
CH - Svizzera	1
CR - Costa Rica	1
EU - Europa	1
GD - Grenada	1
IQ - Iraq	1
JM - Giamaica	1
KE - Kenya	1
LA - Repubblica Popolare Democratica del Laos	1
MD - Moldavia	1
NO - Norvegia	1
PA - Panama	1
PK - Pakistan	1
SD - Sudan	1
UY - Uruguay	1
VE - Venezuela	1
Totale	2.550

Nome	#
A novel clinical tool to classify facioscapulohumeral muscular dystrophy phenotypes	429
A 5-year clinical follow-up study from the Italian National Registry for FSHD	356
Clinical expression of facioscapulohumeral muscular dystrophy in carriers of 1-3 D4Z4 reduced alleles: experience of the FSHD Italian National Registry	327
Large scale population analysis challenges the current criteria for the molecular diagnosis of fascioscapulohumeral muscular dystrophy (FSHD)	275
Large scale genotype-phenotype analyses indicate that novel prognostic tools are required for families with facioscapulohumeral muscular dystrophy.	274
The Italian FSHD registry: An enhanced data integration and analytics framework for smart health care	256
Large genotype-phenotype study in carriers of D4Z4 borderline alleles provides guidance for facioscapulohumeral muscular dystrophy diagnosis	239
D4Z4 reduced allele in myopathic subjects with no FSHD phenotype: why inconsistency between molecular and clinical data should prompt us to further investigations.	231
Phenotypic Variability Among Patients With D4Z4 Reduced Allele Facioscapulohumeral Muscular Dystrophy	185
Totale	2.572

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	330	0	0	0	0	0	66	69	62	24	47	41	21
2021/2022	276	11	16	55	10	12	13	17	23	30	15	53	21
2022/2023	276	28	33	25	18	49	24	6	26	28	1	20	18
2023/2024	182	2	11	11	16	22	11	11	22	8	13	9	46
2024/2025	441	18	17	7	32	78	67	27	51	54	16	29	45
2025/2026	409	48	19	45	91	145	61	0	0	0	0	0	0
Totale													2.572